Clinical Trial Update: A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 study of Cusatuzumab plus Azacitidine in newly diagnosed acute myeloid leukemia patients who are not candidates for intensive chemotherapy. Results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Cusatuzumab (cusatuzumab)

Snippet

Sponsor: OncoVerity, Inc. | Conditions: Leukemia, Myeloid, Acute | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-07-30